Intrathecal immunoglobulin for treatment of adult patients with tetanus: A randomized controlled 2x2 factorial trial
<p>Despite long-standing availability of an effective vaccine, tetanus remains a significant problem in many countries. Outcome depends on access to mechanical ventilation and intensive care facilities and in settings where these are limited, mortality remains high. Administration of tetanus a...
Автори: | Loan, H, Yen, L, Kestelyn, E, Hao, N, Thanh, T, Dung, N, Turner, H, Geskus, R, Wolbers, M, Tan, L, Van Doorn, H, Day, N, Wyncoll, D, Hien, T, Thwaites, G, Vinh Chau, N, Thwaites, C |
---|---|
Формат: | Journal article |
Опубліковано: |
F1000Research
2018
|
Схожі ресурси
-
Intrathecal Immunoglobulin for treatment of adult patients with tetanus: A randomized controlled 2x2 factorial trial
за авторством: Loan, H, та інші
Опубліковано: (2018) -
A pilot study to assess safety and feasibility of Intrathecal Immunoglobulin for the treatment of adults with Tetanus
за авторством: Loan, H, та інші
Опубліковано: (2018) -
Human versus equine intramuscular antitoxin, with or without human intrathecal antitoxin, for the treatment of adults with tetanus: a 2 × 2 factorial randomised controlled trial
за авторством: Van Hao, N, та інші
Опубліковано: (2022) -
Predicting the clinical outcome of tetanus: the tetanus severity score.
за авторством: Thwaites, C, та інші
Опубліковано: (2006) -
Urinary catecholamine excretion, cardiovascular variability, and outcomes in tetanus
за авторством: Du, DH, та інші
Опубліковано: (2023)